AnalystsLeland GershellLeland Gershell's Stock Forecasts
AnalystsLeland Gershell
Analyst Ranking
Top 13%
#554 out of 4565 analysts
Average Return
+20.78%
Win Rate
26%19 out of 74
Risk vs Reward
Poor
Good
Leland Gershell's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Soleno Therapeutics IncSLNO | +1,687.66% | $2.35 | $42.01 | 2023-03-23 - 2024-03-22 | Buy |
Soleno Therapeutics IncSLNO | +662.04% | $4.90 | $37.34 | 2023-09-14 - 2024-04-25 | Buy |
Soleno Therapeutics IncSLNO | +642.35% | $5.03 | $37.34 | 2023-05-24 - 2024-04-25 | Buy |
Crinetics Pharmaceuticals IncCRNX | +144.17% | $17.32 | $42.29 | 2023-08-30 - 2024-04-25 | Buy |
X4 Pharmaceuticals IncXFOR | +73.81% | $0.84 | $1.46 | 2023-03-23 - 2024-03-22 | Buy |
Leland Gershell Analyst Color
Get additional color on Leland Gershell's coverage of popular stocks
Leland Gershell's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Protara Therapeutics IncTARA | 2 | Buy | $30.00 | +883.61% | Maintains | 4 days ago |
Avalo Therapeutics IncAVTX | 1 | Buy | $35.00 | +133.64% | Upgrades | 10 days ago |
Veru IncVERU | 5 | Buy | $5.00 | +313.22% | Reiterates | 11 days ago |
Cue Biopharma IncCUE | 1 | Buy | $10.00 | +609.22% | Maintains | 17 days ago |
Nucana PLCNCNA | 5 | Buy | $100.00 | +2,524.67% | Reiterates | 25 days ago |
Calcimedica IncCALC | 4 | Buy | $14.00 | +164.65% | Maintains | 25 days ago |
Xeris Biopharma Holdings IncXERS | 1 | Buy | $5.00 | +194.12% | Initiates Coverage On | a month ago |
Immunovant IncIMVT | 1 | Buy | $50.00 | +80.18% | Initiates Coverage On | a month ago |
Catalyst Pharmaceuticals IncCPRX | 2 | Buy | $29.00 | +97.55% | Reiterates | a month ago |
Trevi Therapeutics IncTRVI | 2 | Buy | $9.00 | +254.33% | Maintains | a month ago |
Crinetics Pharmaceuticals IncCRNX | 5 | Buy | $55.00 | +30.05% | Maintains | a month ago |
Urogen Pharma LtdURGN | 5 | Buy | $34.00 | +146.02% | Maintains | a month ago |
Lumos Pharma IncLUMO | 4 | Buy | $16.00 | +479.71% | Maintains | 2 months ago |
Soleno Therapeutics IncSLNO | 5 | Buy | $47.00 | +25.87% | Maintains | 4 months ago |
Viridian Therapeutics IncVRDN | 3 | Buy | $36.00 | +183.46% | Maintains | 4 months ago |
Pds Biotechnology CorpPDSB | 3 | Buy | $20.00 | +513.50% | Maintains | 5 months ago |
Milestone Pharmaceuticals IncMIST | 3 | Buy | $13.00 | N/A | Maintains | a year ago |
X4 Pharmaceuticals IncXFOR | 1 | Buy | $4.00 | N/A | Maintains | a year ago |
Alnylam Pharmaceuticals IncALNY | 4 | Buy | $249.00 | N/A | Maintains | a year ago |
Biomarin Pharmaceutical IncBMRN | 1 | Buy | $110.00 | N/A | Upgrades | a year ago |
Argenx SeARGX | 1 | Hold | N/A | N/A | Initiates Coverage On | 2 years ago |
Clene IncCLNN | 1 | Hold | N/A | N/A | Downgrades | 2 years ago |
Plx Pharma IncPLXPQ | 2 | Hold | N/A | N/A | Downgrades | 2 years ago |
Ascendis Pharma AASND | 5 | Buy | $144.00 | N/A | Maintains | 2 years ago |
Horizon Therapeutics Public Ltd CoHZNP | 1 | Buy | $140.00 | N/A | Initiates Coverage On | 2 years ago |
Acasti Pharma IncACST | 3 | Buy | $36.00 | N/A | Initiates Coverage On | 2 years ago |
Opiant Pharmaceuticals IncOPNT | 1 | Buy | $42.00 | N/A | Initiates Coverage On | 2 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 1 | Buy | $12.00 | N/A | Initiates Coverage On | 3 years ago |
Windtree Therapeutics IncWINT | 1 | Buy | $7,200.00 | N/A | Initiates Coverage On | 3 years ago |
Teva Pharmaceutical Industries LtdTEVA | 1 | Hold | N/A | N/A | Initiates Coverage On | 3 years ago |
Casi Pharmaceuticals IncCASI | 1 | Buy | $50.00 | N/A | Initiates Coverage On | 4 years ago |
Vaccinex IncVCNX | 2 | Buy | $1,470.00 | N/A | Maintains | 4 years ago |
Fresh Tracks Therapeutics IncFRTX | 1 | Buy | $5.00 | N/A | Initiates Coverage On | 4 years ago |
Acceleron Pharma IncXLRN | 1 | Buy | $112.00 | N/A | Maintains | 4 years ago |
Epizyme IncEPZM | 1 | Hold | $16.00 | N/A | Downgrades | 4 years ago |
Amarin Corp PLCAMRN | 1 | Hold | N/A | N/A | Upgrades | 4 years ago |
Trevena IncTRVN | 1 | Buy | $325.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.